HCPCS J2506
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (CMS descriptor)
Drugs Drug code Work RVU per service none (2024 fee schedule; adds 0 work RVUs)
Trend
Medicare payment on the code
Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Data years 2022–2024.
Billers
Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Data years 2022–2024.
Trend by year: table3 years
| observed | calculated | calculated | calculated | calculated | calculated | reported | |
|---|---|---|---|---|---|---|---|
| 2024 | 126 | $2,191,365 | -90% | 41,891 | 288 | 699 | 0.00 |
| 2023 | 586 | $22,348,858 | -59% (2023 changed hospital and observation visit codes) | 276,240 | 384 | 1,019 | 0.00 |
| 2022 | 847 | $53,858,179 | not in the 2021 file | 430,820 | 420 | 1,165 | 0.00 |
Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Data years 2022–2024.
By state
Show the table by state5 states
| observed | calculated | calculated | calculated | calculated | calculated | |
|---|---|---|---|---|---|---|
| California | 23 | $308,792 | 6,923 | 276 | 502 | |
| Virginia | 17 | $289,941 | 4,932 | 240 | 502 | |
| Texas | 16 | $261,820 | 4,332 | 246 | 405 | |
| Illinois | 14 | $244,579 | 4,068 | 240 | 537 | |
| Missouri | 14 | $209,157 | 3,096 | 210 | 322 |
Not listed: 13 states with fewer than 11 billers (small cells).
Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Providers placed by practice address. Data year 2024.
Top metro areas
Show the metro areas3 areas
| observed | calculated | calculated | calculated | calculated | |
|---|---|---|---|---|---|
| Virginia Beach-Chesapeake-Norfolk, VA-NC | 17 | $289,941 | 4,932 | 240 | |
| St. Louis, MO-IL | 15 | $256,390 | 3,828 | 216 | |
| Chicago-Naperville-Elgin, IL-IN | 12 | $173,691 | 2,916 | 234 |
Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). The 3 areas with the most payment among those with at least 11 billers; non-metro parts of each state are one area. Data year 2024.
Specialties billing J2506 nationally
Hematology-Oncology accounts for 56% of payment for J2506 nationally in 2024, across 2 specialties on claims.
| observed | calculated | calculated | calculated | calculated | calculated | |
|---|---|---|---|---|---|---|
| Hematology-Oncology | 65 | 52% | $1,221,518 | 56% | 23,135 | 356 |
| Medical Oncology | 39 | 31% | $567,399 | 26% | 10,932 | 280 |
Not listed: 7 specialties with fewer than 11 billers (small cells).
Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Provider-level lines (fewer than 11 beneficiaries suppressed by CMS); specialty is the provider type on claims. Data year 2024.
Top billers of J2506 nationally
Named top billers are a Pro figure, and Pro is not available to buy, so this list is not shown to any account. The counts and totals by state, metro area and specialty on this page are free.
Original Medicare Part B fee-for-service only; CMS suppresses provider lines with fewer than 11 beneficiaries. How these figures are computed · Limitations